Sunghyun Kim
Overview
Explore the profile of Sunghyun Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
175
Citations
1480
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hasunuma T, Grattan C, Eto T, Yagi M, Yazawa R, Kim S, et al.
Immunotherapy
. 2025 Feb;
17(2):113-121.
PMID: 40017397
Aims: To demonstrate pharmacokinetic equivalence of CT‑P39 administered via auto-injector (CT‑P39 AI) and European Union-approved reference omalizumab via pre-filled syringe (EU-OMA PFS) in healthy Japanese adults. Participants & Methods: This...
2.
Kim S, Cho Y
Cognition
. 2025 Feb;
258:106076.
PMID: 40015069
Internalizing regularities between motor responses and stimuli is crucial for adaptive functioning. However, the influence of these regularities on attentional selection remains poorly understood. This study explored whether responses, which...
3.
Lebwohl M, Koo J, Jaworski J, Trefler J, Daniluk S, Dudek A, et al.
Adv Ther
. 2025 Feb;
42(3):1582-1599.
PMID: 39932677
Introduction: This study aimed to demonstrate the interchangeability of biosimilar CT-P17 and European Union reference adalimumab (EU-adalimumab) in a repeated-switch scenario. Methods: In this ongoing, randomized, double-blind, active-controlled, phase 3...
4.
Kim S, Kwon Y, Lee J
Sci Rep
. 2025 Jan;
15(1):2738.
PMID: 39838033
The purpose of this study was to evaluate the difference in the incidence of the hypertensive phase (HP) between Ahmed glaucoma valve (AGV) patients who received intracameral air injection and...
5.
Burmester G, Klimiuk P, Trefler J, Jaworski J, Kim S, Bae Y, et al.
Expert Rev Clin Immunol
. 2025 Jan;
1-9.
PMID: 39803727
Background: CT-P47 is a candidate tocilizumab biosimilar that is currently in clinical development. We assessed the usability of CT-P47 self-administration via auto-injector (AI) in patients with rheumatoid arthritis (RA). Research...
6.
Kwak H, Choi G, Kim S, Park J, Kwon Y, Lee Y, et al.
Sci Rep
. 2025 Jan;
15(1):1613.
PMID: 39794345
Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is a rare and life-threatening blood disorder characterized by the formation of blood clots in small blood vessels. It is caused by antibodies targeting the...
7.
Saini S, Maurer M, Dytyatkovska Y, Springer E, Ratkova M, Krusheva B, et al.
Allergy
. 2025 Jan;
PMID: 39785096
Background: This study compared the therapeutic equivalence of CT-P39 (an omalizumab biosimilar) and EU-approved reference omalizumab (ref-OMA) in patients with chronic spontaneous urticaria. Methods: This double-blind, randomized, active-controlled Phase 3...
8.
Lee E, Jeong M, Park K, Lee D, Lee E, Lee H, et al.
Noncoding RNA
. 2024 Dec;
10(6).
PMID: 39728603
When a body is discovered at a crime or murder scene, it is crucial to examine the body and estimate its postmortem interval (PMI). Accurate estimation of PMI is vital...
9.
Jung S, Park D, Kim S, Oh H
Anal Chem
. 2024 Dec;
96(51):20277-20286.
PMID: 39620427
Hydrogen isotope separation is a complex task due to the nearly identical physical and thermodynamic properties of isotopes, such as deuterium and protium. Traditional methods, including cryogenic distillation, exhibit limitations...
10.
Ahmed J, Kim S
RSC Adv
. 2024 Oct;
14(46):34498-34503.
PMID: 39473800
Sluggish electron transfer from the bacterial metabolic system to the electrode is a critical issue in microbial fuel cell (MFC) research. However, a number of strategies have already been demonstrated...